Deutsche Bank Starts Coverage On Diplomat Pharmacy (DPLO) with $22 Target; Monolithic Power Systems (MPWR) Has 1.09 Sentiment

December 4, 2017 - By Linda Rogers

Among 12 analysts covering Diplomat Pharmacy (NYSE:DPLO), 3 have Buy rating, 1 Sell and 8 Hold. Therefore 25% are positive. Diplomat Pharmacy has $55 highest and $16.0 lowest target. $27.55’s average target is 55.39% above currents $17.73 stock price. Diplomat Pharmacy had 31 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Thursday, November 3 by Mizuho. Leerink Swann downgraded the shares of DPLO in report on Thursday, November 3 to “Mkt Perform” rating. Mizuho maintained it with “Hold” rating and $20.0 target in Tuesday, November 7 report. The firm has “Market Perform” rating given on Thursday, November 3 by Raymond James. Bank of America maintained the stock with “Neutral” rating in Tuesday, June 7 report. The rating was maintained by Mizuho with “Neutral” on Wednesday, May 11. As per Tuesday, October 24, the company rating was maintained by Mizuho. Avondale downgraded the stock to “Mkt Perform” rating in Thursday, November 3 report. The rating was maintained by Mizuho with “Buy” on Wednesday, October 21. Needham maintained Diplomat Pharmacy, Inc. (NYSE:DPLO) on Wednesday, November 8 with “Buy” rating.

Monolithic Power Systems, Inc. designs, develops, and markets integrated power semiconductor solutions and power delivery architectures for consumer, industrial, computing and storage, and communications market divisions. The company has market cap of $4.86 billion. It offers direct current to DC converter integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers, monitors, automobiles, and medical equipment. It has a 82.49 P/E ratio. The firm also provides lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in notebook computers, monitors, car navigation systems, and televisions, as well as for general illumination applications.

The stock decreased 0.95% or $0.17 during the last trading session, reaching $17.73. About 690,017 shares traded. Diplomat Pharmacy, Inc. (NYSE:DPLO) has declined 40.48% since December 4, 2016 and is downtrending. It has underperformed by 57.18% the S&P500.

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company has market cap of $1.22 billion. The firm stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It has a 96.89 P/E ratio. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems.

Investors sentiment increased to 2.27 in 2017 Q2. Its up 1.06, from 1.21 in 2017Q1. It is positive, as 11 investors sold Diplomat Pharmacy, Inc. shares while 33 reduced holdings. 33 funds opened positions while 67 raised stakes. 47.82 million shares or 1.84% less from 48.72 million shares in 2017Q1 were reported. Deutsche State Bank Ag holds 280,399 shares or 0% of its portfolio. Prelude Cap Limited Liability Company holds 2,405 shares. Moreover, Tci Wealth Advisors has 0% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO). Victory Mgmt, a Ohio-based fund reported 1.02M shares. First Trust Advsr Limited Partnership stated it has 71,123 shares or 0% of all its holdings. Iguana Management Limited Co holds 0.63% of its portfolio in Diplomat Pharmacy, Inc. (NYSE:DPLO) for 75,000 shares. Fcg Advsrs Ltd has invested 0.17% in Diplomat Pharmacy, Inc. (NYSE:DPLO). Arizona State Retirement Sys accumulated 22,800 shares. Hermes Inv Mgmt Ltd has 0.39% invested in Diplomat Pharmacy, Inc. (NYSE:DPLO). Fifth Third Retail Bank has 1,079 shares for 0% of their portfolio. Fred Alger Management stated it has 611,501 shares. Employees Retirement System Of Texas stated it has 32,000 shares or 0.01% of all its holdings. Citigroup Inc holds 0% or 201,887 shares in its portfolio. Vanguard Group Inc owns 4.08 million shares for 0% of their portfolio. Guggenheim Capital Lc reported 144,119 shares stake.

Analysts await Diplomat Pharmacy, Inc. (NYSE:DPLO) to report earnings on February, 27. They expect $0.16 earnings per share, up 100.00% or $0.08 from last year’s $0.08 per share. DPLO’s profit will be $11.02 million for 27.70 P/E if the $0.16 EPS becomes a reality. After $0.25 actual earnings per share reported by Diplomat Pharmacy, Inc. for the previous quarter, Wall Street now forecasts -36.00% negative EPS growth.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $1.45 million activity.

Ratings analysis reveals 100% of Monolithic Power’s analysts are positive. Out of 3 Wall Street analysts rating Monolithic Power, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $84.0 while the high is $94.0. The stock’s average target of $89 is -23.91% below today’s ($116.97) share price. MPWR was included in 3 notes of analysts from November 1, 2016. On Friday, February 10 the stock rating was maintained by Needham with “Buy”. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, November 1. Raymond James upgraded Monolithic Power Systems, Inc. (NASDAQ:MPWR) on Monday, November 21 to “Strong Buy” rating.

Zevenbergen Capital Investments Llc holds 2.76% of its portfolio in Monolithic Power Systems, Inc. for 658,035 shares. Summit Creek Advisors Llc owns 111,714 shares or 2.22% of their US portfolio. Moreover, Agf Investments America Inc. has 2.01% invested in the company for 53,083 shares. The Illinois-based Oberweis Asset Management Inc has invested 1.71% in the stock. Whale Rock Capital Management Llc, a Massachusetts-based fund reported 248,254 shares.

The stock decreased 1.17% or $1.38 during the last trading session, reaching $116.97. About 303,042 shares traded or 24.07% up from the average. Monolithic Power Systems, Inc. (MPWR) has risen 53.09% since December 4, 2016 and is uptrending. It has outperformed by 36.39% the S&P500.

Analysts await Monolithic Power Systems, Inc. (NASDAQ:MPWR) to report earnings on February, 8. They expect $0.53 EPS, up 32.50% or $0.13 from last year’s $0.4 per share. MPWR’s profit will be $22.00M for 55.17 P/E if the $0.53 EPS becomes a reality. After $0.55 actual EPS reported by Monolithic Power Systems, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.